Diabetes Care, Vol 18, Issue 8 1160-1167, Copyright © 1995 by American Diabetes Association

ARTICLES

Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy

M Nagamatsu, KK Nickander, JD Schmelzer, A Raya, DA Wittrock, H Tritschler and PA Low
Department of Neurology, Mayo Foundation, Rochester, Minnesota 55905, USA.

OBJECTIVE--To determine whether lipoic acid (LA) will reduce oxidative stress in diabetic peripheral nerves and improve neuropathy. RESEARCH DESIGN AND METHODS--We used the model of streptozotocin-induced diabetic neuropathy (SDN) and evaluated the efficacy of LA supplementation in improving nerve blood flow (NBF), electrophysiology, and indexes of oxidative stress in peripheral nerves affected by SDN, at 1 month after onset of diabetes and in age-matched control rats. LA, in doses of 20, 50, and 100 mg/kg, was administered intraperitoneally five times per week after onset of diabetes. RESULTS--NBF in SDN was reduced by 50%; LA did not affect the NBF of normal nerves but improved that of SDN in a dose-dependent manner. After 1 month of treatment, LA-supplemented rats (100 mg/kg) exhibited normal NBF. The most sensitive and reliable indicator of oxidative stress was reduction in reduced glutathione, which was significantly reduced in streptozotocin-induced diabetic and alpha-tocopherol-deficient nerves; it was improved in a dose-dependent manner in LA-supplemented rats. The conduction velocity of the digital nerve was reduced in SDN and was significantly improved by LA. CONCLUSIONS--These studies suggest that LA improves SDN, in significant part by reducing the effects of oxidative stress. The drug may have potential in the treatment of human diabetic neuropathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. G. Obrosova, V. R. Drel, C. L. Oltman, N. Mashtalir, J. Tibrewala, J. T. Groves, and M. A. Yorek Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1645 - E1655. [Abstract] [Full Text] [PDF]

				I. G. Obrosova, O. Ilnytska, V. V. Lyzogubov, I. A. Pavlov, N. Mashtalir, J. L. Nadler, and V. R. Drel High-Fat Diet Induced Neuropathy of Pre-Diabetes and Obesity: Effects of "Healthy" Diet and Aldose Reductase Inhibition Diabetes, October 1, 2007; 56(10): 2598 - 2608. [Abstract] [Full Text] [PDF]

				D. Ziegler, A. Ametov, A. Barinov, P. J. Dyck, I. Gurieva, P. A. Low, U. Munzel, N. Yakhno, I. Raz, M. Novosadova, et al. Oral Treatment With {alpha}-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy: The SYDNEY 2 trial. Diabetes Care, November 1, 2006; 29(11): 2365 - 2370. [Abstract] [Full Text] [PDF]

				M. J. Stevens, W. Zhang, F. Li, and A. A. F. Sima C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E497 - E505. [Abstract] [Full Text] [PDF]

				S. M Setter, R K. Campbell, and C. J Cahoon Biochemical Pathways for Microvascular Complications of Diabetes Mellitus Ann. Pharmacother., December 1, 2003; 37(12): 1858 - 1866. [Abstract] [Full Text] [PDF]

				M. A. Cotter, K. Ekberg, J. Wahren, and N. E. Cameron Effects of Proinsulin C-Peptide in Experimental Diabetic Neuropathy: Vascular Actions and Modulation by Nitric Oxide Synthase Inhibition Diabetes, July 1, 2003; 52(7): 1812 - 1817. [Abstract] [Full Text] [PDF]

				A. Loimaala, H. V. Huikuri, T. Koobi, M. Rinne, A. Nenonen, and I. Vuori Exercise Training Improves Baroreflex Sensitivity in Type 2 Diabetes Diabetes, July 1, 2003; 52(7): 1837 - 1842. [Abstract] [Full Text] [PDF]

				P. Kempler Review: Autonomic neuropathy: a marker of cardiovascular risk The British Journal of Diabetes & Vascular Disease, March 1, 2003; 3(2): 84 - 90. [Abstract] [PDF]

				A. S. Ametov, A. Barinov, P. J. Dyck, R. Hermann, N. Kozlova, W. J. Litchy, P. A. Low, D. Nehrdich, M. Novosadova, P. C. O'Brien, et al. The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With {alpha}-Lipoic Acid: The SYDNEY Trial Diabetes Care, March 1, 2003; 26(3): 770 - 776. [Abstract] [Full Text] [PDF]

				C. Gedlicka, G. V. Kornek, K. Schmid, and W. Scheithauer Amelioration of docetaxel/cisplatin induced polyneuropathy by {alpha}-lipoic acid Ann. Onc., February 1, 2003; 14(2): 339 - 340. [Full Text] [PDF]

				K. M. Halat and C. E. Dennehy Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy J Am Board Fam Med, January 1, 2003; 16(1): 47 - 57. [Abstract] [Full Text] [PDF]

				H. R. Shotton, S. Clarke, and J. Lincoln The Effectiveness of Treatments of Diabetic Autonomic Neuropathy Is Not the Same in Autonomic Nerves Supplying Different Organs Diabetes, January 1, 2003; 52(1): 157 - 164. [Abstract] [Full Text] [PDF]

				A. M. Schmeichel, J. D. Schmelzer, and P. A. Low Oxidative Injury and Apoptosis of Dorsal Root Ganglion Neurons in Chronic Experimental Diabetic Neuropathy Diabetes, January 1, 2003; 52(1): 165 - 171. [Abstract] [Full Text] [PDF]

				Z. He, C. Rask-Madsen, and G.L. King Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57. [Abstract] [PDF]

				M. J. Sheetz and G. L. King Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA, November 27, 2002; 288(20): 2579 - 2588. [Abstract] [Full Text] [PDF]

				C. Gedlicka, W. Scheithauer, B. Schull, and G.V. Kornek Effective Treatment of Oxaliplatin-Induced Cumulative Polyneuropathy With Alpha-Lipoic Acid J. Clin. Oncol., August 1, 2002; 20(15): 3359 - 3361. [Full Text] [PDF]

				M. Kishi, J. Tanabe, J. D. Schmelzer, and P. A. Low Morphometry of Dorsal Root Ganglion in Chronic Experimental Diabetic Neuropathy Diabetes, March 1, 2002; 51(3): 819 - 824. [Abstract] [Full Text] [PDF]

				M. F. Melhem, P. A. Craven, J. Liachenko, and F. R. DeRubertis {alpha}-Lipoic Acid Attenuates Hyperglycemia and Prevents Glomerular Mesangial Matrix Expansion in Diabetes J. Am. Soc. Nephrol., January 1, 2002; 13(1): 108 - 116. [Abstract] [Full Text] [PDF]

				M. F. MELHEM, P. A. CRAVEN, and F. R. DERUBERTIS Effects of Dietary Supplementation of {{alpha}}-Lipoic Acid on Early Glomerular Injury in Diabetes Mellitus J. Am. Soc. Nephrol., January 1, 2001; 12(1): 124 - 133. [Abstract] [Full Text]

				T. MIYATA, K. KUROKAWA, and C. VAN YPERSELE DE STRIHOU Advanced Glycation and Lipoxidation End Products: Role of Reactive Carbonyl Compounds Generated during Carbohydrate and Lipid Metabolism J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1744 - 1752. [Full Text]

				I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense FASEB J, August 1, 2000; 14(11): 1548 - 1558. [Abstract] [Full Text]

				J. A. Peth, T. R. Kinnick, E. B. Youngblood, H. J. Tritschler, and E. J. Henriksen Effects of a unique conjugate of alpha -lipoic acid and gamma -linolenic acid on insulin action in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R453 - R459. [Abstract] [Full Text] [PDF]